Coverage Guide · Updated April 28, 2026
Does Cigna Cover Mounjaro? (2026 Coverage Guide)
Typically covered for diabetes diagnosis for Cigna members in 2026. Mounjaro is FDA-approved for type 2 diabetes. Coverage depends on your specific plan, employer benefits, and prior authorization rules.
1. Cigna coverage status for Mounjaro
| Detail | Status |
|---|---|
| Plan type | Commercial |
| Coverage status | Typically covered for diabetes diagnosis |
| FDA indication | type 2 diabetes |
| List price | $1023/mo (cash-pay retail) |
| Manufacturer direct | Lilly Direct vials, about $349/mo |
| Appeal success rate | ~41% when denied |
2. Cigna's coverage rules
Cigna covers GLP-1s for the FDA indication on most plans. Express Scripts (Cigna PBM) requires prior authorization with documented BMI 30+ (or 27+ with comorbidity) and prior weight-loss attempts.
3. Prior authorization requirements
Most Cigna plans require:
- BMI 30+ (or 27+ with at least one comorbidity such as type 2 diabetes, hypertension, sleep apnea, or non-alcoholic fatty liver disease)
- Documented prior weight-loss attempts (often 6 months of supervised diet and exercise)
- No contraindications (medullary thyroid carcinoma history, MEN-2)
- Type 2 diabetes diagnosis with elevated A1C (typically 6.5+)
- Some plans require step therapy through a cheaper drug first (often phentermine or metformin)
Prior auth approval typically takes 3 to 14 days. Some prescribers offer PA submission as part of the visit, which speeds the process.
4. If denied: how to appeal
Cigna appeals succeed about 41% of the time when prepared properly. Steps:
- Request the formal denial letter (your right under federal law). It will list the specific reason for denial.
- Have your prescriber write a letter of medical necessity. Should document BMI, comorbidities, prior weight-loss attempts, contraindications to cheaper alternatives, and any cardiovascular risk factors.
- Submit the appeal within the deadline (usually 30 to 180 days depending on plan).
- If denied at first appeal, escalate to second-level review or external review.
5. If uncovered: cheapest alternatives for Cigna members
- Lilly Direct vials: about $349/mo. Direct from the manufacturer, no insurance required.
- Manufacturer savings card: as low as $25/mo for eligible commercial-insurance patients. May apply to your plan.
- Compounded tirzepatide: $80 to $349/mo for compounded semaglutide, $132 to $600/mo for compounded tirzepatide. Cash-pay only.
- Switch to the weight-loss-indicated version (Zepbound or Wegovy) if appropriate, which may have better coverage on plans with obesity benefits.
FAQ
Does Cigna cover Mounjaro in 2026?
Typically covered for diabetes diagnosis for Cigna members. Mounjaro is FDA-approved for type 2 diabetes. Coverage depends on your specific plan, employer benefits (for commercial plans), and prior authorization requirements. Cigna covers GLP-1s for the FDA indication on most plans. Express Scripts (Cigna PBM) requires prior authorization with documented BMI 30+ (or 27+ with comorbidity) and prior weight-loss attempts.
What is the prior authorization process for Mounjaro on Cigna?
Most Cigna plans require: BMI 30+ (or 27+ with comorbidity), documented prior weight-loss attempts (often 6 months), no contraindications, and sometimes step therapy through cheaper drugs first. Approval usually takes 3 to 14 days.
If Cigna denies Mounjaro, can I appeal?
Yes. Cigna appeal success rate for GLP-1 denials is approximately 41%. Strongest appeals document BMI, comorbidities (diabetes, hypertension, sleep apnea, NAFLD), prior weight-loss attempts, and any contraindications to alternative drugs.
If insurance won't cover Mounjaro, what is the cheapest alternative?
Three options. First, Lilly Direct vials from the manufacturer at about $349/mo. Second, the manufacturer savings card if you have commercial insurance ($25/mo for eligible patients). Third, compounded tirzepatide from a licensed compounding pharmacy ($80 to $349/mo for compounded semaglutide, $132 to $600/mo for compounded tirzepatide).